Literature DB >> 8593378

IS6110 restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, south India.

S Das1, C N Paramasivan, D B Lowrie, R Prabhakar, P R Narayanan.   

Abstract

SETTING: Madras, India.
OBJECTIVE: To explore the utility of a standardized IS6110/PvuII deoxyribonucleic acid (DNA) fingerprinting restriction fragment length polymorphism (RFLP) typing method for distinguishing between isolates of Mycobacterium tuberculosis, and to assess the potential for distinguishing between relapse versus reinfection rates.
DESIGN: To assess RFLP heterogeneity in the population, initial isolates, obtained from the sputum of tuberculous 98 patients in diagnosis and follow-up during short-course chemotherapy, were stored and compared. To assess the frequency of disparity between the RFLP type of the initial isolate and one obtained after successful completion of chemotherapy, either during relapse or as an isolated positive culture, 124 isolates comprising 62 such pairs were coded and compared both blind and after decoding.
RESULTS: Although a wide variety of DNA band patterns (fingerprints) was present, the isolates from 39 (40%) of the patients showed a single copy of IS6110. Only 15 pairs of coded initial and follow-up isolates could be identified as having the same band pattern when isolates with zero or single bands were excluded. Nevertheless, after decoding, in a retrospective analysis that included all isolates, those isolates that bacteriologically defined a patient's relapse more often showed RFLP type identity with the initial isolate (19 of 30 comparisons) than did isolates that were obtained as isolated positive cultures (3 of 32 comparisons) (X2 P < 0.001). Tests of sensitivity to chemotherapeutic drugs, catalase activity and resistance to thiophene-2-carboxylic acid hydrazide were of minimal value in discriminating between isolates.
CONCLUSIONS: Despite the high frequency of single- and zero-band isolates in this population, the discriminatory power of RFLP typing with IS6110 is sufficiently high to be useful for clinical and epidemiological studies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8593378     DOI: 10.1016/0962-8479(95)90533-2

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


  64 in total

1.  Discrimination of single-copy IS6110 DNA fingerprints of Mycobacterium tuberculosis isolates by high-resolution minisatellite-based typing.

Authors:  Ann S G Lee; Lynn L H Tang; Irene H K Lim; Richard Bellamy; Sin-Yew Wong
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

2.  Implications of low frequency of IS6110 in fingerprinting field isolates of Mycobacterium tuberculosis from Kerala, India.

Authors:  I Radhakrishnan; M Y K; R A Kumar; S Mundayoor
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

3.  Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countries.

Authors:  Kanchan Ajbani; Shou-Yean Grace Lin; Camilla Rodrigues; Duylinh Nguyen; Francine Arroyo; Janice Kaping; Lynn Jackson; Richard S Garfein; Donald Catanzaro; Kathleen Eisenach; Thomas C Victor; Valeru Crudu; Maria Tarcela Gler; Nazir Ismail; Edward Desmond; Antonino Catanzaro; Timothy C Rodwell
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

4.  Absence of the genetic marker IS6110 from a strain of Mycobacterium tuberculosis isolated in Ontario.

Authors:  S T Howard; M T Oughton; A Haddad; W M Johnson
Journal:  Can J Infect Dis       Date:  1998-01

5.  Characterization of ancestral Mycobacterium tuberculosis by multiple genetic markers and proposal of genotyping strategy.

Authors:  Yong-Jiang Sun; Ann S G Lee; Sze Ta Ng; Sindhu Ravindran; Kristin Kremer; Richard Bellamy; Sin-Yew Wong; Dick van Soolingen; Philip Supply; Nicholas I Paton
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

6.  Evaluation of PCR using TRC(4) and IS6110 primers in detection of tuberculous meningitis.

Authors:  S Narayanan; V Parandaman; P R Narayanan; P Venkatesan; C Girish; S Mahadevan; S Rajajee
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

7.  African 2, a clonal complex of Mycobacterium bovis epidemiologically important in East Africa.

Authors:  Stefan Berg; M Carmen Garcia-Pelayo; Borna Müller; Elena Hailu; Benon Asiimwe; Kristin Kremer; James Dale; M Beatrice Boniotti; Sabrina Rodriguez; Markus Hilty; Leen Rigouts; Rebuma Firdessa; Adelina Machado; Custodia Mucavele; Bongo Nare Richard Ngandolo; Judith Bruchfeld; Laura Boschiroli; Annélle Müller; Naima Sahraoui; Maria Pacciarini; Simeon Cadmus; Moses Joloba; Dick van Soolingen; Anita L Michel; Berit Djønne; Alicia Aranaz; Jakob Zinsstag; Paul van Helden; Françoise Portaels; Rudovick Kazwala; Gunilla Källenius; R Glyn Hewinson; Abraham Aseffa; Stephen V Gordon; Noel H Smith
Journal:  J Bacteriol       Date:  2010-11-19       Impact factor: 3.490

8.  Diagnostic accuracy of in-house PCR for pulmonary tuberculosis in smear-positive patients: meta-analysis and metaregression.

Authors:  S Greco; M Rulli; E Girardi; C Piersimoni; C Saltini
Journal:  J Clin Microbiol       Date:  2009-01-14       Impact factor: 5.948

9.  Molecular and conventional epidemiology of tuberculosis in Hong Kong: a population-based prospective study.

Authors:  Moira Chan-Yeung; Cheuk-Ming Tam; Harriet Wong; Chi-Chiu Leung; Julie Wang; Wing-Wai Yew; Chak-Wah Lam; Kai-Man Kam
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

10.  Genetic identification of Mycobacterium bovis BCG by restriction fragment length polymorphism analysis of the direct-repeat region.

Authors:  S T Howard; A Laszlo; W M Johnson
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.